MedTrace Logo

Supporting Primary Care in Diagnosis and Choice of Treatment for Patients With Psychosocial Symptoms: SGEPsyScan.

NCT01971307 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2015-12-22

No results posted yet for this study

Summary

Although effective treatments for psychosocial symptoms and disorders are available, patients frequently do not receive the most appropriate and effective treatment for their symptoms because of inappropriate and unstructured diagnostics of psychosocial symptoms in general practice. The hypothesis is that by using the intervention SGE-PsyScan the clinical symptoms of patients can be assessed more uniformly and earlier as opposed to the GPs' assessment in usual care. As a result, patients are supposed to start earlier with a treatment that fits the type and severity of their symptoms better.

The patients will be randomly assigned to either receive the SGE-PsyScan or usual care.

Conditions

  • Mental Disorders

Interventions

OTHER

SGE-PsyScan

Sponsors & Collaborators

  • Stichting Gezondheidscentra Eindhoven (SGE)

    collaborator UNKNOWN

  • Stichting Volksgezondheidszorg (VGZ)

    collaborator UNKNOWN

  • Zorgverzekeraar CZ

    collaborator OTHER

  • Maastricht University Medical Center

    lead OTHER

Principal Investigators

  • Mark G Spigt, PhD · Research Institute CAPHRI, Department of Family Medicine, Maastricht University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-12-31
Primary Completion
2015-09-30
Completion
2015-09-30

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01971307 on ClinicalTrials.gov